"Measurable Outcomes Research is a clinical research site dedicated to making a difference in the digestive diseases through our work with patients, sponsors, and CROs."

During the past decade, Measurable Outcomes Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Measurable Outcomes Research" are "CSID" (1 trials), "Colitis, Ulcerative" (1 trials), "Congenital Sucrase-Isomaltase Deficiency" (1 trials) and "Sucrase Isomaltase Deficiency" (1 trials). Many other conditions were trialed in "Measurable Outcomes Research" in a lesser frequency.

Most popular intervention types in "Measurable Outcomes Research" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (1 trials) and "Sucraid (sacrosidase) Oral Solution 8500 IU/mL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Measurable Outcomes Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Measurable Outcomes Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Measurable Outcomes Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Measurable Outcomes Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".